Making the Next Big Thing Possible
Dr. Glenwood Goss is searching for immune biomarkers and using combination therapy in his new clinical trial to help treat non-small-cell lung cancer and – both of which will hopefully lead to a new standard of care for this type of cancer.
Talking to the Public About Your Research – Why Bother?
Dr. Barbara Vanderhyden discusses the importance of science communication and why scientists should engage the public about their research.
It’s in you to fight cancer
BioCanRx was honoured to take part in the Canadian Cancer Survivor Network’s breakfast, “It’s in you to fight cancer,” held on Parliament Hill for Immunotherapy Month. Dr. Kelley Parato, BioCanRx’s Director of Scientific Affairs, spoke at the event about how immunotherapies work and ongoing research in the field.